Vascular Responses to Endothelin-1, Angiotensin-II, and U46619 in Glycerol-Induced Acute Renal Failure

2001 ◽  
Vol 38 (4) ◽  
pp. 569-577 ◽  
Author(s):  
Mohammad A. Newaz ◽  
Adebayo O. Oyekan
2004 ◽  
Vol 19 (1) ◽  
pp. 83-94 ◽  
Author(s):  
M. Jerkic ◽  
Z. Miloradovic ◽  
D. Jovovic ◽  
N. Mihailovic-Stanojevic ◽  
J. V. R. Elena ◽  
...  

1998 ◽  
Vol 152 (2) ◽  
pp. 315-326 ◽  
Author(s):  
Hiroyuki Yanagisawa ◽  
Makoto Nodera ◽  
Yasuhiko Umemori ◽  
Yukio Shimoguchi ◽  
Osamu Wada

2002 ◽  
Vol 103 (s2002) ◽  
pp. 434S-437S ◽  
Author(s):  
Masanori TAKAOKA ◽  
Mikihiro YUBA ◽  
Toshihide FUJII ◽  
Mamoru OHKITA ◽  
Yasuo MATSUMURA

We investigated whether the treatment with 17β-oestradiol has renal protective effects in male rats with ischaemic acute renal failure (ARF). We also examined if the effect of 17β-oestradiol is accompanied by suppression of enhanced endothelin-1 production in postischaemic kidneys. Ischaemic ARF was induced by clamping the left renal artery and vein for 45min followed by reperfusion, 2 weeks after contralateral nephrectomy. Renal function parameters such as blood urea nitrogen, plasma creatinine and creatinine clearance were measured to test the effectiveness of the steroid hormone. Renal function in ARF rats markedly decreased 24h after reperfusion. The ischaemia/reperfusion-induced renal dysfunction was dose-dependently improved by pretreatment with 17β-oestradiol (20 or 100µg/kg, intravenously). Histopathological examination of the kidney of untreated ARF rats revealed severe lesions, such as tubular necrosis, proteinaceous casts in tubuli and medullary congestion, all of which were markedly improved by the higher dose of 17β-oestradiol. In addition, endothelin-1 content in the kidney after the ischaemia/reperfusion increased significantly by approx. 2-fold over sham-operated rats, and this elevation was dose-dependently suppressed by the 17β-oestradiol treatment. These results suggest that oestrogen exhibits protective effects against renal dysfunction and tissue injury induced by ischaemia/reperfusion, possibly through the suppression of endothelin-1 overproduction in postischaemic kidneys.


2020 ◽  
Vol 21 (8) ◽  
pp. 727-733
Author(s):  
Xueqin Feng ◽  
Yumeng Zhang ◽  
Jianying Tao ◽  
Likui Lu ◽  
Yingying Zhang ◽  
...  

Background: Placental blood vessels play important roles in maternal-fetal circulation. Although pathologic mechanisms of preeclampsia are unclear, it is known that placental vascular dysfunction could contribute to pregnant hypertension. However, placental micro-vessel function or dysfunction at preterm has not been investigated. Methods: Human placentas from normal and preeclamptic pregnancies at preterm and term were obtained. Placental micro-vessels were used for determining vascular tension and responses to various vasoconstrictors as well as intracellular calcium store capability. It was the first time to show vascular responses in placental arteries to angiotensin II, endothelin-1, and other vascular drugs at preterm. Results: Compared to the control, placental vascular contractile responses to angiotensin II and caffeine were significantly decreased, while placental vascular responses to KCl, endothelin-1, and bradykinin were not significantly altered in the later term group in preeclampsia. In comparison of placental micro-vessel tension between the preterm and later term, caffeine- and serotonin-induced vascular contractions were significantly weaker in the preterm than that in the later term. On the contrary, vascular response to angiotensin II was increased in the preterm preeclampsia, while KCl-, endothelin-1, and bradykinin-mediated placental vessel responses in the preterm preeclampsia were similar to that in later term preeclampsia. Conclusion: New data showed that micro-vessel responses to angiotensin II and serotonin, not endothelin- 1 or bradykinin, were significantly reduced in the human placentas at preterm, and intracellular Ca2+ store capacity was damaged too, providing important information on possible contributions of placental vascular dysfunction to pregnant hypertension.


1981 ◽  
Vol 36 (1) ◽  
pp. 15-22 ◽  
Author(s):  
H. Huland ◽  
H.J. Augustin ◽  
T. Engels

2003 ◽  
Vol 76 (4) ◽  
pp. 715-720 ◽  
Author(s):  
Christa Mitterbauer ◽  
Christoph Schwarz ◽  
Peter Hauser ◽  
Rudolf Steininger ◽  
Heinz M. Regele ◽  
...  

2004 ◽  
Vol 44 (Supplement 1) ◽  
pp. S459-S461 ◽  
Author(s):  
Yujiro Shibata ◽  
Masanori Takaoka ◽  
Daisuke Maekawa ◽  
Chika Kuwahara ◽  
Yasuo Matsumura

2010 ◽  
Vol 32 (5) ◽  
pp. 559-561 ◽  
Author(s):  
Alfonso López-Ruiz ◽  
Cristina Peso-Gilsanz ◽  
Amparo Meoro-Avilés ◽  
José Soriano-Palao ◽  
Alberto Andreu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document